LuciLaro is a targeted cancer therapy used for tumors with NTRK gene fusions. It is suitable for both adult and pediatric patients with solid tumors.
Active Ingredient
Larotrectinib is a TRK inhibitor that blocks abnormal TRK fusion proteins driving cancer growth.
Uses of LuciLaro
• NTRK fusion-positive solid tumors
• Advanced or metastatic cancers
How LuciLaro Works
It selectively inhibits TRK proteins, stopping tumor cell proliferation.
How to Use LuciLaro
• Take as prescribed
• Can be taken with or without food
Possible Side Effects
• Fatigue
• Dizziness
• Nausea
Precautions
• Monitor liver function
• Avoid pregnancy
Safety Information
Regular follow-up is required for safe use.
Storage
• Store at room temperature
• Keep away from moisture
• Keep out of reach of children
